Humacyte Inc (HUMA : NASDAQ)
Common Stock
$0.44
USD
+0.09 (24.12%)
Last updated: 2026-10-15
Follow HUMA
HUMA
Humacyte Inc
WealthAwesomePerformance
1 Day
+24.12%
1 Week
-1.70%
1 Month
-20.32%
YTD
-54.64%
Key Statistics
Market Cap
$98.37M
52W High
$1.90
52W Low
$0.34
P/E Ratio
-
50 Day MA
$0.58
200 Day MA
$0.85
Beta
2.44
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/15/2026 | $0.37 | $0.45 | $0.35 | $0.44 | $0.44 | 20,672,761 |
| 10/14/2026 | $0.36 | $0.38 | $0.34 | $0.35 | $0.35 | 5,413,386 |
| 10/13/2026 | $0.39 | $0.39 | $0.36 | $0.36 | $0.36 | 12,213,871 |
| 10/12/2026 | $0.40 | $0.41 | $0.39 | $0.39 | $0.39 | 16,313,337 |
| 10/9/2026 | $0.44 | $0.45 | $0.39 | $0.41 | $0.41 | 8,583,000 |
| 10/8/2026 | $0.47 | $0.48 | $0.44 | $0.45 | $0.45 | 5,439,839 |
| 10/7/2026 | $0.48 | $0.48 | $0.46 | $0.47 | $0.47 | 3,903,869 |
| 10/6/2026 | $0.50 | $0.51 | $0.47 | $0.48 | $0.48 | 4,281,127 |
| 10/5/2026 | $0.52 | $0.52 | $0.48 | $0.50 | $0.50 | 6,416,704 |
| 10/2/2026 | $0.51 | $0.53 | $0.50 | $0.52 | $0.52 | 5,370,900 |
Analyst Price Targets
Based on 6 analysts covering HUMA · as of Oct 12, 2026
Wall Street analysts forecast HUMA stock price to rise 269.7% over the next 12 months.
Consensus
Buy4.17 / 5.00
Avg. Target
US$1.63
+269.7% Upside
Current Price
US$0.44
Last close
Analyst Breakdown (6 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HUMA's historical volatility
30-Day Vol
82.3%
Annualized
90-Day Vol
107.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.37
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.41 | US$0.31 – US$0.55 |
| 60 trading days | US$0.39 | US$0.26 – US$0.58 |
| 90 trading days | US$0.37 | US$0.22 – US$0.60 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Humacyte Inc
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.
Financials
- Revenue (TTM)
- $2.12M
- EBITDA
- $-103.23M
- Profit Margin
- 0.00%
- ROE (TTM)
- -547.87%
- EPS (Diluted)
- -0.50
- Book Value
- 0.11
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About HUMA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KNDI | Kandi Technologies Group Inc | $4.11 | +928.50% |
| ESLA | Estrella Immunopharma Inc. | $0.54 | +68.35% |
| SDST | Stardust Power Inc. | $0.04 | +55.38% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $1.36 | +49.70% |
| WETO | Webus International Limited Ordinary Shares | $1.22 | +46.88% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +40.85% |
| DRMA | Dermata Therapeutics Inc | $0.91 | +37.19% |
| LESLQ | Leslie's, Inc. | $0.03 | +35.75% |